Open AccessABO-Incompatible Kidney Transplantation Using Antigen-Specific Immunoadsorption and Rituximab: A 3-Year Follow-up
Author(s) -
Helena Genberg,
Gunilla Kumlien,
Lars Wennberg,
Ulla Berg,
G Tydén
Publication year - 2008
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e3181726849
Subject(s) - immunoadsorption , medicine , kidney transplantation , rituximab , abo blood group system , renal function , transplantation , urology , panel reactive antibody , kidney , creatinine , gastroenterology , surgery , immunology , antibody
In 2001 a protocol for ABO-incompatible (ABOi) kidney transplantation based on antigen-specific immunoadsorption and rituximab was introduced at our center, short-term results being comparable with those of ABO-compatible (ABOc) living donor kidney transplantation. Of greater importance, however, is long-term graft function, thus far not evaluated. The aim of this study was therefore to assess long-term results of this protocol.